Heron Therapeutics (HRTX) Preferred Shares (2025 - 2026)

Heron Therapeutics' (HRTX) quarterly Preferred Shares came in at $1.0 million in Q1 2026, little changed on a QoQ basis from $1.0 million in Q4 2025.

Heron Therapeutics (HRTX) Preferred Shares (2025 - 2026) Analysis & Trends

Heron Therapeutics (HRTX) has 2 years of Preferred Shares data on file, last reported at $1.0 million in Q1 2026.

Quarterly Preferred Shares changed N/A year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.0 million, changed N/A from the prior year.
Preferred Shares steadied at $1.0 million in Q1 2026, from $1.0 million in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $7.9 million in Q3 2025 to a low of $1.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Heron Therapeutics	59.96 Mn	17.29 Mn	26.09 Mn	1.05 Mn

Download Data